AZRADIAL PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of ADIAL PHARMACEUTICALS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AZREsta | — | — | — | — | — | — | — | — | — | — | — | — |
| VBIO | $11M#1 | — | 2.6x#2 | 14.4x#1 | -33.7%#1 | -57.0%#2 | -1012.6%#1 | -209.1%#2 | — | — | -99.2%#1 | — |
| LSTA | $9M#2 | — | 1.1x#1 | 53.3x#2 | -83.0%#2 | 15.0%#1 | -10711.2%#2 | -206.2%#1 | — | 3#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-06.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice